Make your own free website on Tripod.com

Sponsors for KIN Research:

tnplogo.gif

The KIN Consulting & Research Services Company





                                  

                                   Chairman's Views

          The State of the Medical Industry

   Amgen files with ITC against Roche's importation of peg-EPO.    While the US Govt forces Bayer to give up the Cipro Patent.    This is a systemic problem that exists because of the archaic FDA trials and the existing patent laws.   When are the CEO's & the Politicians going to get with the times?

   Modern day technology like Monoclonal Antibody testing has ramped up the testing for side effects.    The old bureacracy of the FDA TRIALS is archaic at best.    The Industry is ignoring a revolutionary medical technique.    Instead they would rather spend Billions on lawsuits:

     A.    Lawsuits cost money!  
     B.   Generics are a matter of fact.
     C.    Monoclonal Antibody testing is the science that kills the
      time lag in drugs coming to market. NEW TECHNOLOGY should
      lead to new laws.   The old Patent laws do not make sense.

   Lets take a closer look at Monoclonal Antibody testing.    In theory they can take the individual stems (For example Epithelial cells) and test them against new antibodies or new antigens.    This is great!    They take everybody part and they test it against the antibody for side effects.    They test mice stems & human stems to be thorough.

   Once Monoclonal antibodies testing becomes the defacto standard testing for side effects, then we can see a change in protocols at the archaic FDA.    Lets steer more finance and attention towards this type of technique.

------------------------------------------------------------------------------

About StemCell Search Results:

     1. Products for Mesenchymal Stem Cells mesenchymal stem cell products for HUMAN CELLSmesenchymal stem cell products for MOUSE CELLS backgoundThe bone marrow stroma was originally thought to function mainly as a structural framework for the hematopoietic component of the marrow. Since...

http://www.stemcell.com/product_catalog/mscproducts.asp

     2. A Novel Marker for Mouse Hematopoietic Stem Cells

A recent publication in Blood by Balazs et al. (2006), demonstrates that mouse bone marrow cells isolated based on Endothelial Protein C Receptor (EPCR) expression alone displayed greater in vivo repopulation activity than cells isolated with traditi...

http://www.stemcell.com/communication/news_releases.asp?id=310

     3. Mouse Neural Stem Cell Research

product categoriesmedia & supplementsneurospheressupport productsSpecial Promotion: Free Neurospheres! Click here for complete details.New NeuroCult® NSC Basal Medium formulation now available. Read the technical bulletin for more inf...

http://www.stemcell.com/product_catalog/munsc.asp

     4. NeuroCult Kits for Human Neural Stem Cell Research

Optimized culture kits for the expansion and differentiation of human neural stem and progenitor cells are now available from StemCell Technologies. The NeuroCult® NS-A Proliferation Kit (Human) contains serum-free medium and supplements for the grow...

http://www.stemcell.com/communication/newspecmed.asp?id=249

     5. NeuroCult Kits for Rat Neural Stem Cell Research

StemCell Technologies offers two complete kits for both the expansion and differentiation of embryonic and adult rat neural stem and progenitor cells. NeuroCult® NS-A Proliferation Kit (Rat) contains serum-free medium and supplements for the growth a...

http://www.stemcell.com/communication/newspecmed.asp?id=250

     6. Non-Hematopoietic Stem Cell Training Workshop

StemCell Technologies Non-Hematopoietic Stem Cell Training Workshop StemCell Technologies is now offering a one-day “hands on” training workshop for instruction on Non-Hematopoietic Stem Cell Culture and Assays. Please note that the workshop dat...

http://www.stemcell.com/communication/news_releases.asp?id=262

     7. StemCell Technologies Receives License from StemCells, Inc. for Supplying Neural Stem Cell Research Products

VANCOUVER, BC, September 17, 2003 – StemCell Technologies, Inc. (“STI”) announced today that it has entered into a long-term license agreement with StemCells, Inc. of Palo Alto, CA (Nasdaq: STEM). The license agreement authorizes STI to manufacture, ...

http://www.stemcell.com/communication/news_releases.asp?id=184

     8. StemSep for human cells

Products for:B Cells> StemSep™ Human B Cell Enrichment Cocktail > StemSep™ Human CD19 Positive Selection Cocktail T Cells> StemSep™ Human T Cell Enrichment Cocktail > StemSep™ Human CD3+ Cell Depletion > StemSep™ Human CD3 Positive Sel...

http://www.stemcell.com/technical/stemsephu.asp

     9. MethoCult - human products (for human cells)product name description applications MethoCult® GF H4434 "Complete" Medium with CytokinesCFU-E, BFU-E, CFU-GM, CFU-G, CFU-M, and CFU-GEMM MethoCult® GF H4534 "Complete" Medium with Cy...

http://www.stemcell.com/product_catalog/metho.asp

     10. MethoCult - mouse products (mouse cells)product name description applications MethoCult® GF M3434 "Complete" Medium with Cytokines BFU-E, CFU-GM, CFU-G, CFU-M, and CFU-GEMM MethoCult® GF M3534 "Complete" Medium with Cytokines (- Epo)...

http://www.stemcell.com/product_catalog/mumetho.asp

     11. NeuroCult Neural Colony Forming Cell (NCFC) Assay Kit

The NeuroCult® NCFC Assay Kit is a single-step collagen-based culture system that has been optimized to support the growth of growth factor-responsive neural stem and progenitor cells. This kit is able to discriminate between colonies derived from ne...

http://www.stemcell.com/communication/newspecmed.asp?id=245

     12. New 2005/2006 StemCell Technologies' Catalog Now Available!

StemCell Technologies' 2005/2006 Catalog is now available. StemCell is committed to providing researchers with cutting-edge life science research tools, and continually endeavors to expand into exciting areas of stem cell biology and relate...

http://www.stemcell.com/communication/news_releases.asp?id=267

     13. New and Improved NeuroCult NSC Basal Medium (Mouse)

StemCell Technologies now offers a new and improved formulation for NeuroCult® NSC Basal Medium (Mouse) which allows for the efficient long-term expansion of mouse neural stem cells (NSCs) and progenitors, and maintenance of their multi-lineage poten...

http://www.stemcell.com/communication/newspecmed.asp?id=251

     14. Production Support Coordinator

StemCell Technologies, a rapidly growing biotechnology company located in Vancouver, BC has an immediate opening for a Production Support Coordinator in our Manufacturing Department. This position will be primarily responsible for coordinating ...

http://www.stemcell.com/career/default.asp?id=307

     15. Products for the in vitro endothelial differentiation of mouse ES cells

Now available: Products to promote sprouting angiogenesis from mouse embryoid bodies in collagen gels.StemCell Technologies offers ES-Cult® products for the maintenance of mouse embryonic stem cells and their in vitro differentiation to a variety of ...

http://www.stemcell.com/communication/newspecmed.asp?id=243

Signed,
 

        /s/
 
Khalid "Kal" I. Natto
The Chairman of the Board
The KIN Consortium
Email:
Kalnatto2000@yahoo.com
Telephone and Voicemail Number: 1(413)-370-2346
Fax Number: 1(610)-300-5883
 

First name:
Last name:
Email address:
Company:
Address 1:
Address 2:
City:
State:
Zip code:
Phone:
Request information
Topic
  


Disclaimer of Warranty and Limitation of Liability
The information, products and services on this web site or letter are provided on an "AS IS," "WHERE IS" and "WHERE AVAILABLE" basis.  The KIN Consortium does not warrant the information or services provided herein or your use of this web site generally, either expressly or impliedly, for any particular purpose and expressly disclaims any implied warranties, including but not limited to, warranties of title, non-infringement, merchantability or fitness for a particular purpose. The KIN Consortium  will not be responsible for any loss or damage that could result from interception by third parties of any information or services made available to you via this web site. Although the information provided to you on this web site is obtained or compiled from sources we believe to be reliable, The KIN Consortium  cannot and does not guarantee the accuracy, validity, timeliness or completeness of any information or data made available to you for any particular purpose. Neither The KIN Consortium , nor any of its affiliates, directors, officers or employees, nor any third party vendor, will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or interruption of this web site, or resulting from the act or omission of any other party involved in making this web site, the data contained herein or the products or services offered on this web site available to you, or from any other cause relating to your access to, inability to access, or use of the web site or these materials, whether or not the circumstances giving rise to such cause may have been within the control of The KIN Consortium  or of any vendor providing software or services. In no event will The KIN Consortium  or any such parties be liable to you, whether in contract or tort, for any direct, special, indirect, consequential or incidental damages or any other damages of any kind even if The KIN Consortium  or any other such party has been advised of the possibility thereof. This limitation on liability includes, but is not limited to, the transmission of any viruses which may infect a user's equipment, failure of mechanical or electronic equipment or communication lines, telephone or other interconnect problems (e.g., you cannot access your internet service provider), unauthorized access, theft, operator errors, strikes or other labor problems. The KIN Consortium  cannot and does not guarantee continuous, uninterrupted or secure access to the web site.

Proprietary Rights
All right, title and interest in this web site and any content contained herein is the exclusive property of The KIN Consortium , except as otherwise stated. Unless otherwise specified, this web site is for your personal and non-commercial use only and you may print, copy and download any information or portion of this web site for your personal use only. You may not modify, copy, distribute, transmit, display, perform, reproduce, publish, license, frame, create derivative works from, transfer, or otherwise use in any other way for commercial or public purposes in whole or in part any information, software, products or services obtained from this web site, except for the purposes expressly provided herein, without The KIN Consortium's prior written approval. If you copy or download any information or software from this web site, you agree that you will not remove or obscure any copyright or other notices or legends contained in any such information.

The KIN Consortium and other trademarks and service marks referenced herein are trademarks and service marks of The KIN Consortium . The names of other companies and third-party products or services mentioned herein may be the trademarks or service marks of their respective owners. You are prohibited from using any marks for any purpose including, but not limited to use as metatags on other pages or sites on the World Wide Web without the written permission of The KIN Consortium  or such third party, which may own the marks.

Pursuant to Section 512(c)(2) of the Copyright Act, The KIN Consortium  designates the following agent to receive notifications of claimed infringement: Khalid I Natto, The KIN Consortium , Email:
kalnatto2000@yahoo.com, Website: http://khalidnatto.tripod.com 

Use of Links
This web site contains links to third party web sites. These links are provided only as a convenience. The inclusion of any link is not and does not imply an affiliation, sponsorship, endorsement, approval, investigation, verification or monitoring by The KIN Consortium of any information contained in any third party web site. In no event shall The KIN Consortium be responsible for the information contained on that site or your use of or inability to use such site. You should also be aware that the terms and conditions of such site and the site's privacy policy may be different from those applicable to your use of this web site.

For New Websites Contact Webmaster at Email: khalidnatto@gmail.com

Feedback, subscriptions, ideas? Email: kalnatto2000@yahoo.com